Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) submitted an application for H-share listing on the Hong Kong Stock Exchange and published the application materials.
Oulin Bio (688319.SH) announced that on November 25, 2025, the company applied to the Hong Kong Stock Exchange...
Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) announced that on November 25, 2025, the company submitted an application to the Hong Kong Stock Exchange for an overseas public offering of shares (H shares) and listing on the main board of the Hong Kong Stock Exchange. The application materials for this issuance and listing were also posted on the Hong Kong Stock Exchange website on the same day.
Related Articles
GMTEight List of A-share restricted sales and lifting restrictions | November 26th
MODERN LAND (01107) will resume trading on November 26th.
Highlights of Securities Firms' Morning Meeting | The new upswing cycle of lithium batteries kicks off, and energy storage is expected to become the core "driver"
GMTEight List of A-share restricted sales and lifting restrictions | November 26th
MODERN LAND (01107) will resume trading on November 26th.
Highlights of Securities Firms' Morning Meeting | The new upswing cycle of lithium batteries kicks off, and energy storage is expected to become the core "driver"
RECOMMEND
Foreign Brands “Take On Chinese Names”: Starbucks And Burger King Change Hands As Chinese Capital’s Localization Scalpel Rewrites Global Rules
25/11/2025
Riding The Momentum Of Gemini 3, “Google Chain” Challenges “Nvidia Chain,” Reshaping The Ai Trading Landscape
25/11/2025
Silver Economy Accelerates As Personal Pension System Marks Three Years — Structural Changes Emerging
25/11/2025
